Glenmark Pharma reports positive data in Phase 2a study of GBR 830 News News / News 6 years ago 496 Views comments Glenmark Pharmaceuticals announced positive data from a Phase 2a study of GBR 830, an investigational, anti-OX40 monoclonal antibody, in atopic dermat... Read more
News Swaraj slams Pakistan at UN; asks why India turns produces engineers, doctors, and they jihadis News / News - 6 years ago
News Paytm Payments Bank logs Rs 30.7 crore loss between August 2016 - March 2017 News / News - 6 years ago
Comments